Kazuhiko Hanada

4PUBLICATIONS
16CO-AUTHORS
Molecular targetsMajor global burdens of diseaseChemotherapyCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 23, 2026
First-in-human, open-label, single-arm phase 1 study of [211At] meta-astatobenzylguanidine in patients with pheochromocytoma or paraganglioma.

|Nov 24, 2023
Assessing Clinical Outcomes of Vancomycin Treatment in Adult Patients with Vancomycin-Susceptible Enterococcus faecium Bacteremia.

Hiroshi Sasano, Kazuhiko Hanada

|Jul 21, 2022
Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection.

Fumiya Watanabe, Koji Furuuchi, Kazuhiko Hanada

|Feb 17, 2018
A quantitative LC/MSMS method for determination of edoxaban, a Xa inhibitor and its pharmacokinetic application in patients after total knee arthroplasty.

Kazuhiko Hanada, Shin-Ichi Matsumoto, Soichi Shibata

Pageof 1

Frequent Collaborators

1 joint publications

Fumiya Watanabe

1 joint publications

Koji Furuuchi

1 joint publications

Keiji Fujiwara

1 joint publications

Kozo Morimoto